Bicycle Therapeutics registers up to $150M additional ADS sale under ATM facility

BICYCLE THERAPEUTICS PLC

Filed prospectus supplement on May 26, 2023, to sell up to $150M in ADSs via existing Sales Agreement with Cantor Fitzgerald and Oppenheimer.
Sales agents will receive 3% commission on gross proceeds; offering is an 'at the market' program under Rule 415.
Company is not obligated to sell any shares; sales at its discretion subject to market conditions.
The original Controlled Equity Offering agreement was dated June 5, 2020.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.